Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camelia Frantz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|October 31, 2018
Regulatory T Cells in Systemic SclerosisCamelia Frantz, Cedric Auffray, Jerome Avouac, et al.
Disease Markers|May 29, 2018
Soluble CD163 as a Potential Biomarker in Systemic SclerosisCamelia Frantz, Sonia Pezet, Jerome Avouac, et al.
La Revue De Medecine Interne|July 9, 2026
[Pasteurella multocida septic arthritis in a native joint: Management dilemmas in a penicillin-allergic patient]Jeanne Chevalier, Margot Guedot, Camelia Frantz, et al.
Clinical and Experimental Rheumatology|May 3, 2021
Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 IndexJérôme Avouac, Raphael Degrave, Helene Vergneault, et al.
Arthritis Research & Therapy|May 31, 2015
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosisNadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Arthritis Research & Therapy|November 14, 2023
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosisNadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Journal of Scleroderma and Related Disorders|February 9, 2024
Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosisManon Lesturgie-Talarek, Virginie Gonzalez, Lucie Beaudoin, et al.
Seminars in Arthritis and Rheumatism|May 3, 2016
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international surveyCamelia Frantz, Jérôme Avouac, Oliver Distler, et al.
Annals of the Rheumatic Diseases|March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosisNadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
Joint Bone Spine|December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthoodAlice Combier, Camelia Frantz, Julien Wipff, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|October 31, 2018
Regulatory T Cells in Systemic SclerosisCamelia Frantz, Cedric Auffray, Jerome Avouac, et al.
Disease Markers|May 29, 2018
Soluble CD163 as a Potential Biomarker in Systemic SclerosisCamelia Frantz, Sonia Pezet, Jerome Avouac, et al.
La Revue De Medecine Interne|July 9, 2026
[Pasteurella multocida septic arthritis in a native joint: Management dilemmas in a penicillin-allergic patient]Jeanne Chevalier, Margot Guedot, Camelia Frantz, et al.
Clinical and Experimental Rheumatology|May 3, 2021
Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 IndexJérôme Avouac, Raphael Degrave, Helene Vergneault, et al.
Arthritis Research & Therapy|May 31, 2015
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosisNadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Arthritis Research & Therapy|November 14, 2023
Retraction Note: Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosisNadira Ruzehaji, Jerome Avouac, Muriel Elhai, et al.
Journal of Scleroderma and Related Disorders|February 9, 2024
Deficiency and altered phenotype of mucosal-associated invariant T cells in systemic sclerosisManon Lesturgie-Talarek, Virginie Gonzalez, Lucie Beaudoin, et al.
Seminars in Arthritis and Rheumatism|May 3, 2016
Impaired quality of life in systemic sclerosis and patient perception of the disease: A large international surveyCamelia Frantz, Jérôme Avouac, Oliver Distler, et al.
Annals of the Rheumatic Diseases|March 11, 2016
Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosisNadira Ruzehaji, Camelia Frantz, Matthieu Ponsoye, et al.
Joint Bone Spine|December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthoodAlice Combier, Camelia Frantz, Julien Wipff, et al.
Pageof 2